Skip to main content

Table 2 Unadjusted and adjusted analysis for nutrition profiles and liver function tests among all adults

From: Hospital change to mixed lipid emulsion from soybean oil-based lipid emulsion for parenteral nutrition in hospitalized and critically ill adults improves outcomes: a pre–post-comparative study

 

Intralipid*

4-OLE

Unadjusted analysis

Adjusted analysis

(N = 341)

(N = 859)

p value

Estimate (95% CI)

p-value

Total days receiving lipids, median (IQR)

8.0 (4.0–12.5)

7.0 (3.0–15.0)

0.62

1.49 (0.11, 2.87)

0.034

Daily lipid dosage (g/kg/day), median (IQR)

0.6 (0.4–0.7)

0.6 (0.4–0.8)

0.041

0.03 (− 0.01, 0.06)

0.11

Daily calories (calories/kg/day), median (IQR)

23.7 (18.8–28.9)

24.8 (19.3–30.6)

0.1

0.18 (− 0.02, 0.37)

0.076

Daily protein (g/kg/day), median (IQR)

0.8 (0.7–1.0)

0.9 (0.7–1.0)

0.06

0.02 (− 0.00, 0.05)

0.0763

Daily dextrose (g/kg/day), median (IQR)

1.5 (1.1–1.9)

1.5 (1.1–2.0)

0.45

0.04 (− 0.04, 0.11)

0.3104

Liver function tests, median (IQR)

Delta AST (units/L)

15.0 (2.0–42.0)

16.0 (2.0–52.5)

0.4

61.9 (− 62.1, 185.8)

0.33

Delta ALT (units/L)

13.0 (0.5–44.5)

16.0 (1.0–54.5)

0.23

44.9 (− 8.6, 98.4)

0.1

Delta ALP (international units/L)

27.0 (3.0–63.0)

26.5 (0.0–104.0)

0.25

29.0 (6.2, 51.8)

0.013

Delta total bilirubin (mg/dL)

0.5 (0.2–1.3)

0.6 (0.1–1.4)

0.85

− 0.4 (− 1.0, 0.2)

0.21

  1. We adjusted for age, sex, race, ethnicity, insurance status, cancer, malnutrition, ED admission, ICU admission, and BMI in kg/m2. The reference was the 4-OLE group
  2. IQR Interquartile range; 4-OLE SMOFLipid
  3. *Intralipid—(Baxter Inc, Deerfield, IL, USA)